Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Relative paucity of p53 gene-mutations in male breast carcinomas.

Seth A, Mariano J, Metcalf R, Li H, Panayiotakis A, Panotopoulou E, Papaevangelou M, Kottaridis S, Papas T.

Int J Oncol. 1993 May;2(5):739-44.

PMID:
21573618
2.

Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population.

Cao AY, Jin W, Shi PC, Di GH, Shen ZZ, Shao ZM.

Breast Cancer Res Treat. 2010 Jan;119(2):295-303. doi: 10.1007/s10549-009-0349-6. Epub 2009 Feb 24.

PMID:
19238535
3.

Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.

Kannan K, Krishnamurthy J, Feng J, Nakajima T, Tsuchida N, Shanmugam G.

Int J Oncol. 2000 Nov;17(5):1031-5.

PMID:
11029509
4.

Li-Fraumeni and Li-Fraumeni-like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements.

Kouidou S, Malousi A, Maglaveras N.

Mol Carcinog. 2009 Oct;48(10):895-902. doi: 10.1002/mc.20537.

PMID:
19367569
5.

Absence of p53 germ-line mutations in bilateral breast cancer patients.

Lidereau R, Soussi T.

Hum Genet. 1992 May;89(2):250-2.

PMID:
1587536
6.

Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.

Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC, Andersen TI, Børresen AL, Li FP, Garber J, et al.

N Engl J Med. 1992 May 14;326(20):1309-15. Erratum in: N Engl J Med. 1997 Mar 6;336(10):734.

7.

A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.

Sarkar FH, Valdivieso M, Borders J, Yao KL, Raval MM, Madan SK, Sreepathi P, Shimoyama R, Steiger Z, Visscher DW, et al.

Diagn Mol Pathol. 1995 Dec;4(4):266-73.

PMID:
8634783
8.

G:C > A:T mutations and potential epigenetic regulation of p53 in breast cancer.

Kouidou S, Malousi A, Kyventidis A, Fragou A, Maglaveras N.

Breast Cancer Res Treat. 2007 Dec;106(3):351-60. Epub 2007 May 16.

PMID:
17505880
9.

Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.

Frebourg T, Barbier N, Yan YX, Garber JE, Dreyfus M, Fraumeni J Jr, Li FP, Friend SH.

Am J Hum Genet. 1995 Mar;56(3):608-15.

10.

Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family.

Evans SC, Mims B, McMasters KM, Foster CJ, deAndrade M, Amos CI, Strong LC, Lozano G.

Hum Genet. 1998 Jun;102(6):681-6.

PMID:
9703430
11.

Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.

Frebourg T, Kassel J, Lam KT, Gryka MA, Barbier N, Andersen TI, Børresen AL, Friend SH.

Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6413-7.

12.

Cancer risks from germ line tumor suppressor gene mutations.

Frebourg T, Malkin D, Friend S.

Princess Takamatsu Symp. 1991;22:61-70. Review.

PMID:
1844252
13.

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, et al.

Science. 1990 Nov 30;250(4985):1233-8. Erratum in: Science. 1993 Feb 12;259(5097):878.

PMID:
1978757
14.

Pattern of p53 gene mutations in breast cancers of women of the midwestern United States.

Sommer SS, Cunningham J, McGovern RM, Saitoh S, Schroeder JJ, Wold LE, Kovach JS.

J Natl Cancer Inst. 1992 Feb 19;84(4):246-52.

PMID:
1734086
15.

[Li-Fraumeni syndrome].

Frebourg T.

Bull Cancer. 1997 Jul;84(7):735-40. Review. French.

16.

Inherited p53 gene mutations in breast cancer.

Sidransky D, Tokino T, Helzlsouer K, Zehnbauer B, Rausch G, Shelton B, Prestigiacomo L, Vogelstein B, Davidson N.

Cancer Res. 1992 May 15;52(10):2984-6.

17.
18.

Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.

Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH, et al.

J Natl Cancer Inst. 1992 Jun 3;84(11):845-55.

PMID:
1317462
19.

Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.

Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Jones PH, Binchy A, Crowther D, et al.

Cancer Res. 1994 Mar 1;54(5):1298-304.

20.

WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.

Lukas J, Groshen S, Saffari B, Niu N, Reles A, Wen WH, Felix J, Jones LA, Hall FL, Press MF.

Am J Pathol. 1997 Jan;150(1):167-75.

Supplemental Content

Support Center